Serum malondialdehyde (MDA) level as a potential biomarker of cancer progression for patients with bladder cancer
Language: English
Page range: 146 - 152
Submitted on: Feb 14, 2020
Published on: Aug 10, 2020
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2020 Zahid Lepara, Orhan Lepara, Almir Fajkić, Damir Rebić, Jasmin Alić, Hajrudin Spahović, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.